Here are the DEF 14A proxy statements from STERIS plc (STE) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow STE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full STE filings page.
STERIS plc is asking shareholders to vote at its July 31, 2026 annual general meeting in Dublin on eight proposals, including electing nine directors, ratifying Ernst & Young as auditors, an advisory say-on-pay vote, and renewing authorities to issue shares and opt out of Irish pre-emption rights.
The proxy highlights a record fiscal 2026, with revenue up 8.7% to $5,935.9 million and net income rising to $782.3 million, or $7.93 per diluted share. Adjusted net income reached $1,003.4 million, or $10.17 per diluted share, and free cash flow grew 24.9% to $982.9 million. Operating cash flow increased 16.8% to $1,341.4 million.
The Board stresses strong governance practices, broad director independence, and a pay-for-performance philosophy. In fiscal 2026, 90.3% of CEO Daniel Carestio’s compensation was variable, with his annual incentive paying out $1,725,007, or 125.1% of target, based entirely on financial metrics. Shareholders of record at June 2, 2026, with 97,457,680 ordinary shares outstanding, are encouraged to vote by proxy.